DermaSensor
Updated: January 22, 2026
Cody Simmons, CEO
Country: USA | Funding: $51.9M (+)
Founded: 2009
Website: https://www.dermasensor.com/
DermaSensor is developing a handheld device for practitioners for detection of skin cancer risk. It is the first FDA-cleared AI-powered skin cancer diagnostic device that enables objective referral prioritization using a 0-10 cancer risk assessment scale. A total of five spectral data points are captured from each skin lesion. The DermaSensor algorithm analyzes the spectral data and provides a skin cancer risk assessment in seconds. The tip of the device reflects and records short bursts of light from the lesion's cellular and subcellular contents. The light is analyzed by a built-in computer, providing information that helps physicians evaluate skin lesions (including melanomas, squamous cell carcinomas and basal cell carcinomas) to determine referral.
Founded: 2009
Website: https://www.dermasensor.com/
DermaSensor is developing a handheld device for practitioners for detection of skin cancer risk. It is the first FDA-cleared AI-powered skin cancer diagnostic device that enables objective referral prioritization using a 0-10 cancer risk assessment scale. A total of five spectral data points are captured from each skin lesion. The DermaSensor algorithm analyzes the spectral data and provides a skin cancer risk assessment in seconds. The tip of the device reflects and records short bursts of light from the lesion's cellular and subcellular contents. The light is analyzed by a built-in computer, providing information that helps physicians evaluate skin lesions (including melanomas, squamous cell carcinomas and basal cell carcinomas) to determine referral.
